Cargando…
Mycobacterium tuberculosis Rv2626c‐derived peptide as a therapeutic agent for sepsis
The Rv2626c protein of Mycobacterium tuberculosis is a promising vaccine candidate owing to its strong serum antibody response in patients with tuberculosis. However, there is limited information regarding the intracellular response induced by Rv2626c in macrophages. In this study, we demonstrated t...
Autores principales: | Kim, Sun Young, Kim, Donggyu, Kim, Sojin, Lee, Daeun, Mun, Seok‐Jun, Cho, Euni, Son, Wooic, Jang, Kiseok, Yang, Chul‐Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721357/ https://www.ncbi.nlm.nih.gov/pubmed/33258196 http://dx.doi.org/10.15252/emmm.202012497 |
Ejemplares similares
-
Toxoplasma gondii GRA8-derived peptide immunotherapy improves tumor targeting of colorectal cancer
por: Kim, Jae-Sung, et al.
Publicado: (2020) -
Multi-Functional MPT Protein as a Therapeutic Agent against Mycobacterium tuberculosis
por: Kim, Jae-Sung, et al.
Publicado: (2021) -
Toxoplasma gondii GRA9 Regulates the Activation of NLRP3 Inflammasome to Exert Anti-Septic Effects in Mice
por: Kim, Jae-Sung, et al.
Publicado: (2020) -
IFN-γ and IgG responses to Mycobacterium tuberculosis latency antigen Rv2626c differentiate remote from recent tuberculosis infection
por: Amiano, Nicolás O., et al.
Publicado: (2020) -
Evaluation of Rv0220, Rv2958c, Rv2994 and Rv3347c of Mycobacterium tuberculosis for serodiagnosis of tuberculosis
por: You, Xiaolong, et al.
Publicado: (2017)